Rare diseases
Rare diseases are characterized by their low prevalence, high complexity, and significant impact on patients’ lives, particularly in settings where access to specialized treatments is limited. At ELEA EXELTIS, we focus our efforts on the development and availability of therapies for these conditions, supporting medical teams across the region in the management of diseases that require specific and sustained solutions.
| BRAND NAME | ACTIVE INGREDIENT | INDICATION | COMMERCIALIZATION |
|---|---|---|---|
|
Everpressin
|
Terlipressin | Treatment of bleeding esophageal varices and acute hepatorenal syndrome (type 1). |
|
|
Everpressin Terlipressin Treatment of bleeding esophageal varices and acute hepatorenal syndrome (type 1). |
|||
|
Exabant
|
Icatibant | Acute attacks of hereditary angioedema types I and II. |
|
|
Exabant Icatibant Acute attacks of hereditary angioedema types I and II. |
|||
|
Fedonax
|
Pirfenidone | Idiopathic pulmonary fibrosis, to slow disease progression. |
 
|
|
Fedonax Pirfenidone Idiopathic pulmonary fibrosis, to slow disease progression. |
|||
|
Ricentan
|
Macitentan | Pulmonary arterial hypertension. |
 
|
|
Ricentan Macitentan Pulmonary arterial hypertension. |
|||
|
Rofekxr
|
Tofacitinib | Treatment of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PA), ulcerative colitis (UC), and polyarticular course juvenile idiopathic arthritis (pcJIA) |
|
|
Rofekxr Tofacitinib Treatment of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PA), ulcerative colitis (UC), and polyarticular course juvenile idiopathic arthritis (pcJIA) |
|||
|
Tachyben
|
Urapidil | Hypertensive emergencies and blood pressure control in perioperative and postoperative settings. |
|
|
Tachyben Urapidil Hypertensive emergencies and blood pressure control in perioperative and postoperative settings. |
|||